Patents
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
07/2010
07/01/2010CA2750841A1 Pyrimidine indole derivatives for treating cancer
07/01/2010CA2748251A1 Novel bicyclic heterocyclic compound
07/01/2010CA2748249A1 Cyclic amine compounds
07/01/2010CA2748218A1 Novel polymorphic forms of 6-(1-methyl-1h-pyrazol-4-yl)-2-{3-[5-(2-morpholin-4-yl-ethoxy)-pyrimidin-2-yl]-benzyl}-2h-pyridazin-3-one dihydrogenphosphate and processes of manufacturing thereof
07/01/2010CA2747863A1 Pyridazinone derivatives
07/01/2010CA2747784A1 Pharmaceutical compounds
07/01/2010CA2744911A1 Fused imidazole derivatives as trpv3 antagonist
06/2010
06/30/2010EP2202228A1 Amide compounds and use of the same
06/30/2010EP2201011A2 Novel compounds having indazole frameworks, methods for preparing the same and pharmaceutical composition comprising the same
06/30/2010EP2201003A1 Process for the preparation of zolmitriptan, salts and solvates thereof
06/30/2010EP2201002A1 5-ht7 receptor antagonists
06/30/2010EP2200998A1 Azacyclylisoquinolinone and isoindolinone derivatives as histamine-3 antagonists
06/30/2010EP2200990A1 Gamma secretase modulators
06/30/2010EP2200989A1 Isoquinolinyl and isoindolinyl derivatives as histamine-3 antagonists
06/30/2010EP2200975A1 Dual-acting antihypertensive agents
06/30/2010EP2200609A1 Compounds for the treatment of metabolic disorders
06/30/2010EP2200436A1 Substituted pyrimidinyl-amines as protein kinase inhibitors
06/30/2010EP1618107B1 Condensed n-heterocyclic compounds and their use as crf receptor antagonists
06/30/2010EP1476435B1 Novel pyridin- and pyrimidin-derivatives
06/30/2010EP1366760B1 Tablets quickly disintegrated in oral cavity
06/30/2010EP1278735B1 2,4-di(hetero-)arylamino(-oxy)-5-substituted pyrimidines as antineoplastic agents
06/30/2010CN101765598A Fungicide N-5-membered fused heteroaryl-methylene-N-cycloalkyl-carboxamide derivatives
06/30/2010CN101765597A Pyrimidine derivatives as inhibitors of phosphatidylinositol-3-kinase
06/30/2010CN101765596A Inhibitors of hypoxia inducible factor (HIF) useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
06/30/2010CN101765591A Pyrimidine derivatives useful for the treatment of inflammatory or allergic conditions
06/30/2010CN101765590A 1,(3,)5-substituted imidazoles, their use in the treatment of hypertension and methods for their preparation
06/30/2010CN101765430A New pyrazol derivatives
06/30/2010CN101759690A Pyrazol amidine derivative and application thereof in agriculture
06/30/2010CN101759685A Organic electroluminescent iridium coordination compound and preparation method and application thereof
06/30/2010CN101759645A P38 inhibitors and methods of use thereof
06/30/2010CN101759625A Method for synthesizing sutent intermediate
06/29/2010US7745639 Dihydropyrazoles; anticarcinogenic agents can be synergistically combined with one or more active ingredients; side effect reduction
06/29/2010US7745638 Anticancer agents; such as 4-acetylamino-1H-pyrazole-3-carboxylic acid (4-fluoro-phenyl)-amide
06/29/2010US7745623 Cyclic amide derivative, and its production and use
06/29/2010US7745475 Heteroaryl benzamide derivatives as GLK activators
06/29/2010US7745473 Indole derivative for alkylating specific base sequence of DNA and alkylating agent and drug containing the derivative
06/29/2010US7745460 LFA1 related immune and/or inflammatory disorders; interactions with leukointegrins; such as fused nitrogen heterocyclic secondary amine derivatives
06/29/2010US7745458 (1S,5R)-3-[4-(4-phenyl-2-pyrimidinyl)butyl]-1-[4-(trifluoromethyl)phenyl]-3-azabicyclo[3.1.0]hexane, used for the treatment of drug abuse and dependence, urogenital disorders, as cognition activators and as antipsychotic agents
06/29/2010US7745453 Hydroxypyrimidinone derivatives having inhibitory activity against HIV integrase
06/29/2010US7745444 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
06/29/2010US7745442 Methods of reducing risk of infection from pathogens
06/29/2010US7745437 Compounds and compositions as protein kinase inhibitors
06/29/2010US7745426 vitamin B6-based component selected from pyridoxal, pyridoxamine or pyridoxine chemically linked to antiepileptic agents, neuroprotectants, neurotransmitters or nootropic agents, used for the treatment of epilepsy
06/29/2010CA2557856C 3-'4-heterocyclyl-1,2,3,-triazol-1-yl!-n-aryl-benzamides as inhibitors of the cytokines production for the treatment of chronic inflammatory diseases
06/29/2010CA2455987C Tetrahydroindolone and purine derivatives linked to arylpiperazines
06/24/2010WO2010071846A2 Compounds for treating neuropsychiatric conditions
06/24/2010WO2010071837A1 Pyrazine derivatives useful as inhibitors of atr kinase
06/24/2010WO2010070032A1 Cyclic pyrimidin-4-carboxamides as ccr2 receptor antagonists for treatment of inflammation, asthma and copd
06/24/2010WO2010069966A1 Substituted indazole derivatives active as kinase inhibitors
06/24/2010WO2010069879A1 Pyrrole derivatives for use as plant growth regulators
06/24/2010WO2010069833A1 Pyrimidin- 2 -ylamino derivatives and their use to treat inflammation
06/24/2010WO2010044543A3 Heterocyclic compound as protein kinase inhibitor
06/24/2010WO2010042887A3 Methods for preparing oxazolidinones and compositions containing them
06/24/2010WO2010038948A3 Arylpiperazine-containing pyrrole 3-carboxamide derivatives for treating depressive disorders
06/24/2010WO2010038086A3 P38 map kinase inhibitors
06/24/2010WO2010024586A3 Novel benzamide derivative compound, and a method for producing same
06/24/2010WO2010019832A3 Amide-extended crosslinking compounds and methods for use thereof
06/24/2010WO2010002777A3 Process for the preparation of benzoimidazol-2-yl pyrimidine derivatives
06/24/2010WO2009155527A3 Phosphatidylinositol 3 kinase inhibitors
06/24/2010WO2009106470A3 Angiotensin ii receptor antagonists
06/24/2010US20100160646 Processes for preparing sunitinib and salts thereof
06/24/2010US20100160644 Novel processes of making hydroxy-1-azo-derivatives as tpo mimetics
06/24/2010US20100160629 Cyclic amide derivative, and its production and use
06/24/2010US20100160406 Histamine h3 receptor agents, preparation and therapeutic uses
06/24/2010US20100160402 Bisbenzimidazoles as antimalarial agents
06/24/2010US20100160360 Jnk modulators
06/24/2010US20100160343 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by vla-4
06/24/2010US20100160341 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by vla-4
06/24/2010US20100160340 Protein kinase inhibitors
06/24/2010US20100160336 Azabicyclo (3.1.0) Hexane Derivatives Useful As Modulators Of Dopamine D3 Receptors
06/24/2010US20100160335 Pyridazinone derivative and pde inhibitor containing the same as active ingredient
06/24/2010US20100160331 Novel carbamoyloxy arylalkan arylpiperazine compound, pharmaceutical compositions comprising the compound and method for treating pain, anxiety and depression by administering the compound
06/24/2010US20100160330 Novel bicyclic heterocycles useful as selective androgen receptor modulators
06/24/2010US20100160328 New compounds useful for dpp-iv enzyme inhibition
06/24/2010US20100160325 4-(3-aminopyrazole) pyrimidine derivatives for use as tyrosine kinase inhibitors in the treatment of cancer
06/24/2010US20100160324 Pyrazole derivatives as that modulate the activity of cdk, gsk and aurora kinases
06/24/2010US20100160323 NOVEL PIPERAZINE DERIVATIVES AS INHIBITORS OF STEAROYL-CoA DESATURASE
06/24/2010US20100160322 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
06/24/2010US20100160319 Histamine h3 receptor agents, preparation and therapeutic uses
06/24/2010US20100160318 3-Pyrrolo[b]Cyclohexylene-2-Dihydroindolinone Derivatives and Uses Thereof
06/24/2010US20100160316 Quinazolines useful as modulators of ion channels
06/24/2010US20100160315 Novel 2, 3-diamino-quinazolinone derivatives and their medical use
06/24/2010US20100160311 Fungicidal Azolopyrimidines, Process for Their Preparation and Their Use For Controlling Harmful Fungi, and Also Compositions Comprising Them
06/24/2010US20100160303 Carbazole carboxamide compounds useful as kinase inhibitors
06/24/2010US20100160302 Novel dipeptidyl peptidase iv inhibitors and processes for their preparation and pharmaceutical compositions containing them
06/24/2010US20100160292 Kinase Inhibitors, and Methods of Using and Identifying Kinase Inhibitors
06/24/2010US20100160287 Compounds useful as inhibitors of janus kinases
06/24/2010US20100160286 Heteroarylcarbamoylbenzene derivatives for the treatment of diabetes
06/24/2010US20100160283 Heteroaryl-substituted alkyne compounds and method of use
06/24/2010US20100160280 Aminopyridine and carboxypyridine compounds as phosphodiesterase 10 inhibitors
06/24/2010US20100160263 7,9-substituted tetracycline compounds
06/24/2010US20100160164 Substituted 1-(diazinyl)pyrazol-4-ylacetic acids, processes for their preparation and their use as herbicides and plant growth regulators
06/24/2010US20100159596 Small molecule compounds for stem cell differentiation
06/24/2010US20100159593 Transfection reagents
06/24/2010US20100158992 Piperazine-substituted pyridazinone derivatives useful as glucan synthase inhibitors
06/24/2010US20100158863 Triazoloanilinopyrimidine derivatives for use as antiviral agents
06/24/2010US20100158862 Hepatitis C Virus Inhibitors
06/24/2010US20100154889 Electrolyte composition and dye-sensitized solar cell using the same
06/24/2010CA2747677A1 Cyclic pyrimidin-4-carboxamides as ccr2 receptor antagonists for treatment of inflammation, asthma and copd
06/24/2010CA2747252A1 Pyrazine derivatives useful as inhibitors of atr kinase